Mevalone, which is authorised for professional use on grapevines and apples, is granted authorisation in the country
Eden Research has announced that it has been granted regulatory authorisation for use of its flagship biofungicide Mevalone in Germany.
Mevalone is authorised for professional use on grapevines and apples, to control Botrytis on grapes and for the prevention of storage diseases on apples.
“Today’s news marks the fourth significant regulatory announcement over the past 12 months,” said Sean Smith, CEO of Eden Research.
”It is another sign of real progress for our corporate growth strategy that we are able to deliver an additional market entry opportunity for an existing product which will add meaningful revenue within three years of product launch.
”In the context of our EU addressable market, Germany is a particularly notable territory gain for Eden and Mevalone given the prevalence of fungal disease in the cooler conditions in which wine grapes and apples are grown,” he continued.
”It is also encouraging to note the German regulator’s support for products such as Mevalone as, like growers across Europe and the UK, German farmers are increasingly challenged by the removal of conventional pesticides from the market.
”Mevalone is the perfect tool to sustainably support farmers with efficacious products that help protect their crops, yields and profits,” Smith added.
“We will be working with our commercial partner SumiAgro Germany over the coming months to optimise the commercial strategy for the region in time for the next growing season.”
